TerrAscend Corp. (TSNDF)
OTCMKTS
· Delayed Price · Currency is USD
0.3850
-0.0150 (-3.75%)
May 27, 2025, 4:00 PM EDT
TerrAscend Revenue
TerrAscend had revenue of $71.00M in the quarter ending March 31, 2025, a decrease of -11.95%. This brings the company's revenue in the last twelve months to $297.04M, down -9.59% year-over-year. In the year 2024, TerrAscend had annual revenue of $306.68M, down -3.36%.
Revenue (ttm)
297.04M
Revenue Growth
-9.59%
P/S Ratio
0.39
Revenue / Employee
281.02K
Employees
1,163
Market Cap
114.48M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 306.68M | -10.65M | -3.36% |
Dec 31, 2023 | 317.33M | 69.50M | 28.04% |
Dec 31, 2022 | 247.83M | 53.62M | 27.61% |
Dec 31, 2021 | 194.21M | 62.06M | 46.96% |
Dec 31, 2020 | 132.15M | 68.34M | 107.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |
TerrAscend News
- 19 days ago - TerrAscend Corp. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 19 days ago - TerrAscend outlines M&A strategy and projects further cost reductions amid Q1 2025 results - Seeking Alpha
- 19 days ago - TerrAscend Corp. (TSNDF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - TerrAscend Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - TerrAscend Closes on Ohio Dispensary Acquisition - GlobeNewsWire
- 22 days ago - TerrAscend Signs Agreement to Acquire Fourth Dispensary in New Jersey - GlobeNewsWire
- 2 months ago - High Potential: U.S. Marijuana Penny Stocks to Watch This April - MarijuanaStocks
- 2 months ago - TerrAscend Corp. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha